Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kanthikiran Varanasi"'
Autor:
K Mukkanti, Swaroop Vakkalanka, Sridhar Veeraraghavan, Kanthikiran Varanasi, Satheeshmanikandan R S Thappali
Publikováno v:
Journal of Mass Spectrometry. 47:1612-1619
A sensitive and reliable high-performance liquid chromatography–mass spectrometry (LC–MS/MS) was developed and validated for simultaneous quantification IC87114, roflumilast (RFM), and its active metabolite roflumilast N-oxide (RFN) using tolbuta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0799520c488c368cbc63967a140b6f87
https://doi.org/10.1002/jms.3103
https://doi.org/10.1002/jms.3103
Publikováno v:
Biopharmaceutics & Drug Disposition. 33:455-465
Cilostazol (CLZ) and atorvastatin (ATV) are often co-prescribed to treat conditions such as peripheral arterial disease. In the present study, the drug-drug interaction potential of multi-dose ATV co-administration with CLZ on both pharmacokinetics a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f386838be8db2abff6b3169712f2b220
https://doi.org/10.1002/bdd.1812
https://doi.org/10.1002/bdd.1812
Autor:
Satheeshmanikandan R S Thappali, Mukkanti Khagga, Swaroop Vakkalanka, Rambabu Arla, Sridhar Veeraraghavan, Kanthikiran Varanasi, Sandhya Chennupati, Madheswaran Rajamanickam
Publikováno v:
Scientia Pharmaceutica
Volume 80
Issue 3
Pages 633-646
Volume 80
Issue 3
Pages 633-646
A new method for the simultaneous determination of celecoxib, erlotinib, and its active metabolite desmethyl-erlotinib (OSI-420) in rat plasma, by liquid chromatography/tandem mass spectrometry with positive/negative ion-switching electrospray ioniza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6e354a2e6adef3a84086a0651c9b29e
http://europepmc.org/articles/PMC3447620
http://europepmc.org/articles/PMC3447620
Autor:
Shraddha Rajak, Aditya Narasimha Murthy, Rahul Vats, Kanthikiran Varanasi, Rambabu Arla, Sridhar Veeraraghavan
Publikováno v:
Journal of Pharmacy and Pharmacology. 64:1638-1645
Objectives Atorvastatin (ATV) and cilostazol (CLZ) are often co-prescribed to treat conditions such as peripheral arterial disease. In the present study, the drug–drug interaction potential of multi-dose CLZ on both pharmacokinetics and the lipid-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12319ba5ffd936619e60cf478a7c4812
https://doi.org/10.1111/j.2042-7158.2012.01542.x
https://doi.org/10.1111/j.2042-7158.2012.01542.x
Autor:
R. Prasanna, Srikant Viswanadha, Meyyappan Muthuppalaniappan, Sridhar Veeraraghavan, Swaroop Vakkalanka, Nagarathnam Dhanapalan, Kanthikiran Varanasi, Babu Govindarajulu
Publikováno v:
Cancer Research. 72:3741-3741
Background: Phosphoinositide-3 kinase (PI3K) belongs to a class of intracellular lipid kinases that phosphorylate the 3 position hydroxyl group of the inositol ring of phosphotidylinositol. The PI3K pathway is frequently activated in human cancers an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::091155b1b4bce6a89c7a21189976dd6d
https://doi.org/10.1158/1538-7445.am2012-3741
https://doi.org/10.1158/1538-7445.am2012-3741
Autor:
Nagarathnam Dhanapalan, Srikant Viswanadha, Sumalatha Kuppireddi, Meyyappan Muthuppalaniappan, Sridhar Veeraraghavan, Babu Govindarajulu, Swaroop Vakkalanka, Kanthikiran Varanasi, Prashant Kashinath Bhavar
Publikováno v:
Cancer Research. 72:1789-1789
Background: c-Met is a proto-oncogene that encodes the protein Met with intrinsic tyrosine kinase activity. Aberrant Met kinase activity triggers a series of unwarranted phosphorylation events and signalling processes that ultimately lead to the deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f825114a5c061dd557744e317c029c62
https://doi.org/10.1158/1538-7445.am2012-1789
https://doi.org/10.1158/1538-7445.am2012-1789
Autor:
Govindarajulu Babu, Srikant Viswanadha, Swaroop Vakkalanka, Meyyappan Muthuppalaniappan, Sridhar Veeraraghavan, Kanthikiran Varanasi
Publikováno v:
Cancer Research. 71:4489-4489
Background: Phosphoinositide-3 kinase (PI3K) belongs to a class of intracellular lipid kinases that phosphorylate the 3 position hydroxyl group of the inositol ring of phosphotidylinositol. The PI3K pathway is frequently activated in human cancers an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22e61afc6f273e0b29a6b6618b306b05
https://doi.org/10.1158/1538-7445.am2011-4489
https://doi.org/10.1158/1538-7445.am2011-4489
Autor:
Srikant Viswanadha, Gayatriswaroop Merikapudi, Sumalatha Kuppireddi, Meyyappan Muthuppalaniappan, Swaroop Vakkalanka, Kanthikiran Varanasi, Sridhar Veeraraghavan
Publikováno v:
Cancer Research. 71:2599-2599
Background: Non-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer and is one of the leading causes of cancer-related mortality across the globe. Majority of the NSCLC are characterized by the presence of ras mutation thereby re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05cb813f8ffcc75ce4cfa342ead81cdf
https://doi.org/10.1158/1538-7445.am2011-2599
https://doi.org/10.1158/1538-7445.am2011-2599
Autor:
Srikant Viswanadha, Sridhar Veeraraghavan, Swaroop Vakkalanka, Kanthikiran Varanasi, Sumalatha Kuppireddi, Meyyappan Muthuppalaniappan, Prasad Babu Kakarla, Sivan Perumal Murugan, Josephrajan Thainashmuthu
Publikováno v:
Molecular Cancer Therapeutics. 8:C212-C212
Background: Receptor tyrosine kinases (RTK) represent a class of high affinity cell surface receptors that play a critical role in the development and progression of several types of cancers. Among the receptor tyrosine kinases, c-Met mediates divers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17548446cea1d056ca29353eb8554769
https://doi.org/10.1158/1535-7163.targ-09-c212
https://doi.org/10.1158/1535-7163.targ-09-c212